FRAMINGHAM, Mass. and SYDNEY, Nov. 6 /PRNewswire-FirstCall/ -- HeartWare
International, Inc. (Nasdaq: HTWR; ASX: HIN) a leading innovator and provider
of less invasive, miniaturized circulatory support technologies
revolutionizing the treatment of advanced heart failure, today announced that
it is scheduled to make presentations at two upcoming investor conferences in
November.
The first presentation will be made at the Third Annual Canaccord Adams
Cardiovascular Conference at 9:00 am PST on Tuesday, November 10. The one-day
conference will be held at the Nikko Hotel in San Francisco.
The second presentation will be made at the Lazard Capital Markets Sixth
Annual Healthcare Conference at 10:30 am EST on Wednesday, November 18. The
conference will be held at the St. Regis Hotel in New York City, November
17-18.
Live webcasts of the Company's presentations at the conferences will be
available via a link provided at www.heartware.com. Archived replays of the
presentations will also be available shortly after the presentation time for a
period of at least 60 days.
About HeartWare International
HeartWare International develops and manufactures miniaturized implantable
heart pumps, or left ventricular assist devices, to treat Class IIIb and Class
IV patients suffering from advanced heart failure. The HeartWare® Ventricular
Assist System features the HVAD(TM) pump, a small full-output circulatory
support device (up to 10L/min flow) designed to be implanted next to the
heart, avoiding the abdominal surgery generally required to implant competing
devices. HeartWare has received CE Marking for the HeartWare® Ventricular
Assist System in the European Union. The device is currently the subject of a
150-patient clinical trial in the United States for a Bridge-to-Transplant
indication.
For further information:
US Investor Relations
Matt Clawson
Partner
Allen & Caron Inc
Email: matt@allencaron.com
Tel: +1 949 474 4300
SOURCE HeartWare International, Inc.
US Investor Relations, Matt Clawson, Partner, Allen & Caron Inc,
+1-949-474-4300, matt@allencaron.com, for HeartWare International, Inc.
